Your browser doesn't support javascript.
loading
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Hamdi, Yosr; Soucy, Penny; Adoue, Véronique; Michailidou, Kyriaki; Canisius, Sander; Lemaçon, Audrey; Droit, Arnaud; Andrulis, Irene L; Anton-Culver, Hoda; Arndt, Volker; Baynes, Caroline; Blomqvist, Carl; Bogdanova, Natalia V; Bojesen, Stig E; Bolla, Manjeet K; Bonanni, Bernardo; Borresen-Dale, Anne-Lise; Brand, Judith S; Brauch, Hiltrud; Brenner, Hermann; Broeks, Annegien; Burwinkel, Barbara; Chang-Claude, Jenny; Couch, Fergus J; Cox, Angela; Cross, Simon S; Czene, Kamila; Darabi, Hatef; Dennis, Joe; Devilee, Peter; Dörk, Thilo; Dos-Santos-Silva, Isabel; Eriksson, Mikael; Fasching, Peter A; Figueroa, Jonine; Flyger, Henrik; García-Closas, Montserrat; Giles, Graham G; Goldberg, Mark S; González-Neira, Anna; Grenaker-Alnæs, Grethe; Guénel, Pascal; Haeberle, Lothar; Haiman, Christopher A; Hamann, Ute; Hallberg, Emily; Hooning, Maartje J; Hopper, John L; Jakubowska, Anna; Jones, Michael.
Afiliação
  • Hamdi Y; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada.
  • Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada.
  • Adoue V; Institut National de la Santé et de la Recherche Médicale U1043, Toulouse, France.
  • Michailidou K; Centre National de la Recherche Scientifique, Toulouse, France.
  • Canisius S; Université de Toulouse, Université Paul Sabatier, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.
  • Lemaçon A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Droit A; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  • Andrulis IL; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Anton-Culver H; Centre de Recherche du CHU de Québec - Université Laval, Faculté de Médecine, Département de Médecine Moléculaire, Université Laval, Quebec, Canada.
  • Arndt V; Centre de Recherche du CHU de Québec - Université Laval, Faculté de Médecine, Département de Médecine Moléculaire, Université Laval, Quebec, Canada.
  • Baynes C; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
  • Blomqvist C; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Bogdanova NV; Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
  • Bojesen SE; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Bonanni B; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Borresen-Dale AL; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  • Brand JS; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Brauch H; Copenhagen General Population Study, Herlevand Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Brenner H; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Broeks A; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Burwinkel B; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Chang-Claude J; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Couch FJ; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Cox A; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Cross SS; University of Tübingen, Tübingen, Germany.
  • Czene K; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
  • Darabi H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
  • Dennis J; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
  • Devilee P; Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany.
  • Dörk T; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Dos-Santos-Silva I; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Eriksson M; Molecular Epidemiology Group, German Cancer Research Center, Heidelberg, Germany.
  • Fasching PA; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Figueroa J; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • García-Closas M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Giles GG; Sheffield Cancer Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Goldberg MS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
  • González-Neira A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Grenaker-Alnæs G; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Guénel P; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Haeberle L; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Haiman CA; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Hamann U; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Hallberg E; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  • Hooning MJ; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Hopper JL; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Jakubowska A; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
  • Jones M; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.
Oncotarget ; 7(49): 80140-80163, 2016 Dec 06.
Article em En | MEDLINE | ID: mdl-27792995
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 4 / Neoplasias da Mama / Biomarcadores Tumorais / Polimorfismo de Nucleotídeo Único Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 4 / Neoplasias da Mama / Biomarcadores Tumorais / Polimorfismo de Nucleotídeo Único Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá